These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4539631)

  • 21. [Studies on the effect of metabolites and antimetabolites with Trichomonas vaginalis as a model. 3. Studies on essential fatty acids].
    Christow CP
    Zentralbl Bakteriol Orig A; 1971 Sep; 218(1):128-37. PubMed ID: 4400116
    [No Abstract]   [Full Text] [Related]  

  • 22. [Studies on the effect of metabolites and antimetabolites with Trichomonas vaginalis as a model. II. Studies on the vitamin K-group].
    Christow CP
    Zentralbl Bakteriol Orig A; 1971 Sep; 218(1):116-27. PubMed ID: 4400115
    [No Abstract]   [Full Text] [Related]  

  • 23. Sensitivity of Trichomonas vaginalis to metronidazole in medium with different concentrations of iron and ascorbate.
    Meingassner JG; Heyworth PG
    J Parasitol; 1982 Dec; 68(6):1163-5. PubMed ID: 6983569
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis, anti-mycobacterial, anti-trichomonas and anti-candida in vitro activities of 2-substituted-6,7-difluoro-3-methylquinoxaline 1,4-dioxides.
    Carta A; Loriga M; Paglietti G; Mattana A; Fiori PL; Mollicotti P; Sechi L; Zanetti S
    Eur J Med Chem; 2004 Feb; 39(2):195-203. PubMed ID: 14987828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antibacterial, antifungal and antiprotozoal activity of a preparation based on benzalkonium chloride].
    Bastianini L
    Farmaco Prat; 1974 Oct; 29(10):594-601. PubMed ID: 4213948
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of Cladonia alpestris on Trichomonas vaginalis in vitro].
    Wu J; Zhang M; Ding D; Tan T; Yan B
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(2):126-9. PubMed ID: 7554162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of oxygen and carbon dioxide on the growth of Trichomonas vaginalis and Tritrichomonas foetus.
    Mack SR; Müller M
    J Parasitol; 1978 Oct; 64(5):927-9. PubMed ID: 309937
    [No Abstract]   [Full Text] [Related]  

  • 28. [An in vitro test of propolis against Trichomonas vaginalis].
    Xu BH; Shi MZ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Dec; 24(6):477-8. PubMed ID: 17366987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel oxidized derivatives of antifungal pyrrolnitrin from the bacterium Burkholderia cepacia K87.
    Sultan Z; Park K; Lee SY; Park JK; Varughese T; Moon SS
    J Antibiot (Tokyo); 2008 Jul; 61(7):420-5. PubMed ID: 18776654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxicity of hamycin for Trichomonas vaginalis, HeLa and BHK-21.
    Lushbaugh WB; Cleary JD; Finley RW
    J Antimicrob Chemother; 1995 Nov; 36(5):795-802. PubMed ID: 8626260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experiments on the influence of metabolites and antimetabolites on the model of Trichomonas vaginalis. X. Experiments with amino-acids].
    Christow CP
    Zentralbl Bakteriol Orig A; 1972 Mar; 219(3):390-3. PubMed ID: 4145215
    [No Abstract]   [Full Text] [Related]  

  • 32. Synthesis of new pyrroles and their biological activities.
    Chavan VP; Mane AS; Bhawsar SB; Hangarge RV; Shingare MS
    Hindustan Antibiot Bull; 1999; 41(1-4):32-4. PubMed ID: 12024978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and antimicrobial activity of some 1,5-diaryl-2-methyl-3- carbethoxy-4-(4-methyl-piperazin-1-ylmethyl)-pyrroles and some 1,5-diaryl-2- methyl-3,4-di(4-methyl-piperazin-1-ylmethyl)-pyrroles.
    Cerreto F; Scalzo M; Villa A
    Farmaco; 1993 Dec; 48(12):1735-46. PubMed ID: 8135996
    [No Abstract]   [Full Text] [Related]  

  • 34. Vitamin B12 requirement for the growth of Trichomonas vaginalis in vitro.
    Hollander DH; Leggett NC
    J Parasitol; 1985 Oct; 71(5):683-4. PubMed ID: 3877156
    [No Abstract]   [Full Text] [Related]  

  • 35. [A strain of Trichomonas vaginalis with reduced sensitivity for metronidazole].
    Dijkmans BA; Polderman AM; Heintz AP; van Furth R
    Ned Tijdschr Geneeskd; 1982 Nov; 126(48):2193-5. PubMed ID: 6983659
    [No Abstract]   [Full Text] [Related]  

  • 36. Antifungal agents. 7. Dichlorophenylpyrrylimidazolylmethane derivatives: synthesis and antifungal activities.
    Massa S; Mai A; Ragno R; Porretta GC; Retico A; Simonetti G; Artico M
    Farmaco; 1994 Jan; 49(1):51-5. PubMed ID: 8185750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Disparaged leukorrhea and resistant forms of Trichomonas vaginalis].
    Hainaux H
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):367-9. PubMed ID: 4549774
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis of some diguanidino 1-methyl-2,5-diaryl-1H-pyrroles as antifungal agents.
    Jana GH; Jain S; Arora SK; Sinha N
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3592-5. PubMed ID: 15978808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Action "in vitro" of 5,7-dichloro-beta-oxyquinaldine on Trichomonas vaginalis].
    FABIO U
    Nuovi Ann Ig Microbiol; 1960; 11():48-52. PubMed ID: 13821205
    [No Abstract]   [Full Text] [Related]  

  • 40. [In vitro sensitivity of Trichomonas vaginalis to canestan (clotrimazole)].
    Szarmach H; Malyszko E; Zaremba A; Trybula J; Poniecka H; Zajac W; Stepka L
    Przegl Dermatol; 1976; 63(6):819-22. PubMed ID: 1087423
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.